Editorial: FDA seems too cozy with manufacturers of pain pills

Oct. 11, 2013 @ 12:00 AMPain pill abuse is arguably today's most devastating drug abuse trend.Illicit marijuana use is more prevalent, with an estimated 31 million saying they have used pot or hash in the past year, according to the 2012 National Survey on Drug Use and Health.But the number of people abusing pain pills has risen to about 12.5 million -- about three times the level of cocaine or hallucinogens, according to the survey -- and the impact on families and crime is much more severe. The link between prescription drug addiction and rising rates of heroin use only makes it worse.Even more disturbing is that these are legal drugs, sanctioned by the government and generating billions in profits for drug manufacturers and distributors. Unfortunately, both the regulators and the industry could have done more to avoid the explosion of abuse, and the sometimes cozy relationship between the two could be a big part of the problem.This week, the Washington Post put the spotlight on that issue with a report that private companies paid as much as $25,000 to participate in the Food and Drug Administration's advisory panel discussions on federal regulations for prescription painkillers.The panel was organized by two medical professors, Robert Dworkin of the University of Rochester and Dennis Turk of the University of Washington, to give FDA advice on how to evaluate evidence from clinical trials, the newspaper reported. The money went to the researchers and not the FDA, but it rai...

Source: PharmaGossip - October 11, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs